FibroGen's GAAP loss for 2020 was $189.291 million, up 2.5 times from $76.97 million in the previous year. Revenue decreased 31.3% to $176.319 million from $256.577 million a year earlier.
FibroGen's GAAP loss for 2020 was $189.291 million, up 2.5 times from $76.97 million in the previous year. Revenue decreased 31.3% to $176.319 million from $256.577 million a year earlier. 
fibrogen.gcs-web.com
English (US) 